Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alterity Therapeutics's enterprise value was $16.21M on Nov 11, 2026, against $2.72B a year earlier. Over the last 5 years it ranged from -$12.20M to $4.06B, with a median of $415.73M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.21M | -99.3% |
| 2025 | Dec 31, 2025 | $2.32B | +61.3% |
| 2024 | Dec 31, 2024 | $1.44B | +190.4% |
| 2023 | Dec 29, 2023 | $495.51M | – |
| 2022 | Dec 30, 2022 | -$9.72M | -311.4% |
| 2021 | Dec 31, 2021 | $4.60M | -64.4% |
| 2020 | Dec 31, 2020 | $12.90M | – |
| 2019 | Dec 31, 2019 | -$2.12M | -423.5% |
| 2018 | Dec 31, 2018 | $654.71K | -93.9% |
| 2017 | Dec 29, 2017 | $10.66M | – |
| 2016 | Dec 30, 2016 | -$6.17M | – |
See a number that looks wrong?